Jenkem Technology Co., Ltd. (SHA:688356)

China flag China · Delayed Price · Currency is CNY
105.46
-0.67 (-0.63%)
Mar 10, 2026, 3:00 PM CST
Market Cap6.38B +90.1%
Revenue (ttm)316.09M +39.2%
Net Income63.39M +112.5%
EPS1.05 +114.3%
Shares Out60.50M
PE Ratio100.44
Forward PEn/a
Dividend0.15 (0.14%)
Ex-Dividend DateJul 11, 2025
Volume1,091,853
Average Volume933,001
Open106.20
Previous Close106.13
Day's Range105.00 - 109.08
52-Week Range47.17 - 118.68
Beta0.98
RSI62.45
Earnings DateApr 29, 2026

About Jenkem Technology

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG pro... [Read more]

Sector Materials
Founded 2001
Employees 269
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688356
Full Company Profile

Financial Performance

In 2025, Jenkem Technology's revenue was 316.09 million, an increase of 39.19% compared to the previous year's 227.10 million. Earnings were 63.39 million, an increase of 112.46%.

Financial Statements